TG, Ildong in Asian ublituximab deal

TG Therapeutics Inc. (OTCBB:TGTX) granted Ildong Pharmaceutical Co. Ltd. (Seoul, South Korea) exclusive rights to develop and commercialize ublituximab in South Korea and Southeast Asia. TG Therapeuti...